VEGFA and macular retinal edema: After understanding that VEGF has an important role in the pathogenesis of macular edema, ranibizumab has been used in treatment of macular edema due to RVO with intravitreal administration.7-9 The aim of treatment is to minimize photoreceptor damage by decreasing the duration of edema.10